I am not a professional advisor. Seek professional advice before investing or trading.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nah... I doubt it.
Well... that may have been the last opportunity to get under 60c. Have a great long weekend gang!
Or it could simply be a double-top from running up 13% in an hour! It's consolidating at 60c.
Its in the Think or Swim platform. No way to link to it, but look at the very bottom last line...
9/4/20 01:20:00
Gilles Della Corte , M.D., Chief Medical Officer of Relief, said: "Relief is developing a potentially ground-breaking, life-saving treatment for critically ill COVID-19 patients, and I am honored to be part of this important work in a therapeutic area with such a huge unmet medical need. I am also excited that aviptadil has broad potential to help patients with other acute and chronic lung diseases, as well as earlier-stage COVID-19 patients, and also look forward to planning and overseeing clinical development in these areas. As a medical doctor, there is nothing more rewarding than helping patients who are in desperate need of new treatment options."
Relief also reported today that the Company has hired Virtuoso Sarl, a strategic and tactical, operational and trial delivery services firm, as Clinical Trials Manager to set up and run aviptadil clinical trials in Europe . Clinical trials in the U.S. will continue to be managed by NeuroRx .
About Relief Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Its lead drug candidate aviptadil, synthetic vasoactive intestinal peptide (VIP), is being tested in two phase 2/3 trials in COVID-19 induced ARDS (acute respiratory distress syndrome), plus an expanded access program (compassionate use). Aviptadil is the first COVID-19 therapeutic to demonstrate the ability to block replication of the SARS-CoV-2 virus in human lung cells and monocytes, while also preventing synthesis of cytokines in the lung. Aviptadil was granted Fast Track Designation and emergency use IND authorization from the U.S. Food and Drug Administration (FDA).
Relief holds orphan drug designations from the U.S. FDA and the European Union for the use of VIP to treat ARDS, pulmonary hypertension, and sarcoidosis. Relief also holds a U.S. patent (US8178489 formulation for aviptadil) for RLF-100 and proprietary manufacturing processes for its synthesis.
RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF.
CONTACT RELIEF THERAPEUTICS Holding AG Raghuram (Ram) Selvaraju Chairman of the Board Mail: contact@relieftherapeutics.com
FOR MEDIA INQUIRES: MC Services AG Anne Hennecke / Brittney Sojeva Mail: relief@mc-services.eu Tel.: +49 (0) 211-529-252-14
Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding SA and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of RELIEF THERAPEUTICS Holding SA to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. RELIEF THERAPEUTICS Holding SA is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
SOURCE: Relief Therapeutics Holdings AG
View source version on accesswire.com: https://www.accesswire.com/604785/Relief-Appoints-Gilles-Della-Corte-MD-as-Chief-Medical-Officer
The announcement about the CMO hit my TD Ameritrade newswire at 1:20pm (an hour ago)
Hahaha... I thought it was done for the day... turned my computer off, then read your comment lol I didn't even know it was going up :)
A strong finish on rlftf's stock? I doubt it... most traders/investors are gone for the day, including the Swiss. Holiday weekend, the market clears out early... see you on Tuesday!
The reason why we are not getting media coverage on large scale media outlets is because they don't want the attention yet. When word gets out that they have THE drug of the decade, its going to nothing but worldwide mass hysteria. They need to be prepared to meet the demand, and they need to have the proven results well-documented before it is announced. At that time, they won't even need to try to get the word out... it will take on a life of its own. You will see... it will be here before you know it.
Just worth reiterating, as many people seem fixated on small daily price movements. Whether you feel defeated by a gap down or warm & fuzzy over a gap up, FDA approval/denial will wipe that feeling out instantly. When that time comes, each of us will wish we were either in or out, or glad we were or weren't. The FDA holds the keys to the kingdom; everything else is just a peek inside. Have a great evening everyone!
From a pure chart perspective, the 1hr chart is shaping up nicely.
Haha same value, different perspective ;) Thanks for fixing that lol
Hahaha good analogy :)
The mechanics do... so I suppose they are profiting from this, and if so, in their own personal accounts? And that's not regulated?
Serious question here... I don't understand how MMs manipulate. Can you please explain? Are you saying they buy shares being sold (or hold on to them) until the price gets too high, and then they start selling them to put downward pressure? I'm not familiar with the back-end of the house if someone could please explain.
Cuz he's terrible with social media lololol
Last night, I wrote a post talking about the Amis and the Swiss, and how we have a "core group" of long and strong investors for quite some time now. Last week the price consolidated and stabilized between 55c and 60c without much news, establishing our own sort of current market cap among ourselves. We watched people come and go and attack us all week, but we all held strong and steady, not letting any shares go... that is OUR BASE (the long Amis and Swiss), and we're locked and loaded, waiting for news. From there, we will move up and down over the coming days as new people come and go... these movements are irrelevant, compared to what we are waiting for.
I hold 2 positions... a large position, waiting patiently for announcements, and a much smaller 1/8th position to move in and out to catch a few bucks and to keep me occupied, cuz this is a lot like watching grass grow, and I'm more of a mow-the-lawn kinda guy.
Here's my Amis & Swiss post for some additional encouragement...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157984190
Do I smell a little breakout?
I'm on TOS... just bought more. Maybe your issue is fixed now?
Well... I sure am hoping that means the two locations are no longer needed to complete the trials :) (speculation of course)
What exactly does this mean? What are the details?
GEM "entered into an Option Agreement with Yves Sagot"
Amis & Swiss
Hey guys... hope everyone is having a great weekend.
Just a few observations I want to share before the start of the week.
Yesterday, I woke up to the scary prospect of dilution with $700M worth of warrants being executed. I though "how did I miss that"!?!? However, I have now had great relief (i've been waiting to use that pun) with all the great work everyone has done to dissect that situation and provide clarity... including the Swiss team! Thanks!
There is a core group of original investors on both sides - the Amis side and the Swiss side - working at different hours and feeding off of each other's great work. Two teams, far apart, slowly coming together to bring confidence to this incredible opportunity for each other. This level of confidence is beginning to attract new retail investors. Its great work... its adding value to the investment... and its greatly appreciated. I couldn't possibly get to all this info without everyone's help. Thanks!
Last week, we saw the stock consolidate and stabilize amongst these two Amis and Swiss teams (the original core retail investors). The new base price has been established between 55c and 60c. And now, over the weekend, I have seen a large increase in exposure to RLFTF through other boards and social media outlets, and hey... even a petition :) Word of this life-saving drug is finally spreading faster and faster. Be aware, these new entrants into the investment may not have the conviction we have and may not have done the DD yet. They will be easily shaken from day to day until news hits... but we know where and with whom the base is... the unshakable Amis and Swiss!
So now... it looks like we've waded through many of the dangerous waters, and our 2 ships are getting closer to the shoreline - "it will come as surely as amen in the church". The next couple of weeks should be an exciting part of the journey. Let's steer this in diligently and carefully as we have in the past. Good luck this week to all my new Amis and Swiss friends! I will soon see you on the shoreline.
WOW! This is HUGE news! A week old apparently??? When/where did u get this?
Took the day off... just getting caught up. Great job on the petition... lol I feel like this is turning into a movement!
Well... I'm thinking more of the Flo-Jo type legs...
Was he fired? Have a closer look.
Haha... hoping Ms. RLFTF has some nice legs on her :)
Have a GREAT weekend everyone!
Thank you for bringing this to our attention... great find! Good work making the connection! I have mulled over it a bit and have come to this conclusion... I don't think it damages our chances of getting through the FDA... at worst, its a slap on the wrist for the embarrassment and a good scapegoat for the FDA. But to your point... it most certainly shows how good the relationships are. Thanks again!
LOL... you are absolutely right!
We might get above that .570 and .574 before the end of the day... that would nice.
lol just funny how that happened right on ur post :)
Well... I would agree, accept I just looked at the chart... and the volume spike and high green candle right now.
Yes... it represents significant political support.
I also had trouble getting filled for 10k shares... it took a couple min... I was finally just filled a couple seconds ago.
Very nice... we broke .57 resistance :)